[go: up one dir, main page]

GB9713667D0 - Enhancement of intestinal permeability - Google Patents

Enhancement of intestinal permeability

Info

Publication number
GB9713667D0
GB9713667D0 GBGB9713667.5A GB9713667A GB9713667D0 GB 9713667 D0 GB9713667 D0 GB 9713667D0 GB 9713667 A GB9713667 A GB 9713667A GB 9713667 D0 GB9713667 D0 GB 9713667D0
Authority
GB
United Kingdom
Prior art keywords
enhancement
intestinal permeability
intestinal
permeability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9713667.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
University of Maryland Baltimore
Original Assignee
Cortecs Ltd
University of Maryland Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd, University of Maryland Baltimore filed Critical Cortecs Ltd
Priority to GBGB9713667.5A priority Critical patent/GB9713667D0/en
Publication of GB9713667D0 publication Critical patent/GB9713667D0/en
Priority to EP98932308A priority patent/EP0994720A1/fr
Priority to JP50539099A priority patent/JP2002511867A/ja
Priority to PCT/GB1998/001895 priority patent/WO1999000141A1/fr
Priority to AU82254/98A priority patent/AU8225498A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22033—Fruit bromelain (3.4.22.33), i.e. juice bromelain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9713667.5A 1997-06-27 1997-06-27 Enhancement of intestinal permeability Pending GB9713667D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9713667.5A GB9713667D0 (en) 1997-06-27 1997-06-27 Enhancement of intestinal permeability
EP98932308A EP0994720A1 (fr) 1997-06-27 1998-06-26 Utilisation de la bromelaine pour la fabrication d'un medicament renfor ant la permeabilite intestinale
JP50539099A JP2002511867A (ja) 1997-06-27 1998-06-26 腸管透過性を増強させるための医薬の製造におけるブロメラインの使用
PCT/GB1998/001895 WO1999000141A1 (fr) 1997-06-27 1998-06-26 Utilisation de la bromelaine pour la fabrication d'un medicament renforçant la permeabilite intestinale
AU82254/98A AU8225498A (en) 1997-06-27 1998-06-26 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713667.5A GB9713667D0 (en) 1997-06-27 1997-06-27 Enhancement of intestinal permeability

Publications (1)

Publication Number Publication Date
GB9713667D0 true GB9713667D0 (en) 1997-09-03

Family

ID=10815076

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9713667.5A Pending GB9713667D0 (en) 1997-06-27 1997-06-27 Enhancement of intestinal permeability

Country Status (5)

Country Link
EP (1) EP0994720A1 (fr)
JP (1) JP2002511867A (fr)
AU (1) AU8225498A (fr)
GB (1) GB9713667D0 (fr)
WO (1) WO1999000141A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826822A (ja) * 1981-08-10 1983-02-17 Kaken Pharmaceut Co Ltd 慢性腎炎治療剤
WO1985003438A1 (fr) * 1984-02-03 1985-08-15 Advanced Drug Technology Corporation Compositions eupeptiques et contenant des enzymes
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain

Also Published As

Publication number Publication date
EP0994720A1 (fr) 2000-04-26
JP2002511867A (ja) 2002-04-16
AU8225498A (en) 1999-01-19
WO1999000141A1 (fr) 1999-01-07

Similar Documents

Publication Publication Date Title
PL339551A1 (en) Derivatives of rezorcin
IL131484A0 (en) Treatment of cardiomyopathy
GB2330182B (en) Manufacture of gaskets
PL334769A1 (en) Derivatives of 5-aroylnaphtene
GB2324224B (en) Method of call screening
GB9713667D0 (en) Enhancement of intestinal permeability
PL338777A1 (en) Derivative of piperidinylmethyloxazolydinone
ZA985064B (en) Derivatives of pentaerythrits
GB2323652B (en) Means of assembly
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB2322372B (en) Preparation of 2-Mercaptothiazole
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
PL323567A1 (en) Swimming aid
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps
PL319263A1 (en) Novel derivative of pyrimidinylcarbazole
PL327430A1 (en) Set of shaped components
TW357554U (en) Improvement of shinguards
GB9804204D0 (en) Invalid aid
CA83884S (en) Set of screens
CA83885S (en) Set of screens
GB9724088D0 (en) Treatment of dyskinesia
TW316466U (en) Structure of hangtag
TW314733U (en) Structure of hairclip